BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 12487830)

  • 1. The efficacy of heparinization in prolonging patency of arterial and central venous catheters in children: a randomized double-blind trial.
    de Neef M; Heijboer H; van Woensel JB; de Haan RJ
    Pediatr Hematol Oncol; 2002 Dec; 19(8):553-60. PubMed ID: 12487830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin or 0.9% sodium chloride to maintain central venous catheter patency: a randomized trial.
    Schallom ME; Prentice D; Sona C; Micek ST; Skrupky LP
    Crit Care Med; 2012 Jun; 40(6):1820-6. PubMed ID: 22488006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial.
    Garland JS; Alex CP; Henrickson KJ; McAuliffe TL; Maki DG
    Pediatrics; 2005 Aug; 116(2):e198-205. PubMed ID: 15995005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keeping central venous lines open: a prospective comparison of heparin, vitamin C and sodium chloride sealing solutions in medical patients.
    Rabe C; Gramann T; Sons X; Berna M; González-Carmona MA; Klehr HU; Sauerbruch T; Caselmann WH
    Intensive Care Med; 2002 Aug; 28(8):1172-6. PubMed ID: 12185445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer.
    Cesaro S; Tridello G; Cavaliere M; Magagna L; Gavin P; Cusinato R; Zadra N; Franco Zanon G; Zanesco L; Carli M
    J Clin Oncol; 2009 Apr; 27(12):2059-65. PubMed ID: 19273702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, controlled trial of heparin versus placebo infusion to prolong the usability of peripherally placed percutaneous central venous catheters (PCVCs) in neonates: the HIP (Heparin Infusion for PCVC) study.
    Shah PS; Kalyn A; Satodia P; Dunn MS; Parvez B; Daneman A; Salem S; Glanc P; Ohlsson A; Shah V
    Pediatrics; 2007 Jan; 119(1):e284-91. PubMed ID: 17200252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial for maintaining peripheral intravenous lock in children.
    Mok E; Kwong TK; Chan MF
    Int J Nurs Pract; 2007 Feb; 13(1):33-45. PubMed ID: 17244243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefit and risk of heparin for maintaining peripheral venous catheters in neonates: a placebo-controlled trial.
    Klenner AF; Fusch C; Rakow A; Kadow I; Beyersdorff E; Eichler P; Wander K; Lietz T; Greinacher A
    J Pediatr; 2003 Dec; 143(6):741-5. PubMed ID: 14657819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of heparin-coated central venous lines to prevent catheter-related bloodstream infection.
    Abdelkefi A; Achour W; Ben Othman T; Ladeb S; Torjman L; Lakhal A; Ben Hassen A; Hsairi M; Ben Abdeladhim A
    J Support Oncol; 2007 Jun; 5(6):273-8. PubMed ID: 17624052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of saline vs heparin in maintaining 24-gauge intermittent intravenous catheters in a rabbit model.
    Kyle LA; Turner BS
    Neonatal Netw; 1999 Sep; 18(6):49-54. PubMed ID: 10690098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of indwelling central venous catheter sepsis.
    Daghistani D; Horn M; Rodriguez Z; Schoenike S; Toledano S
    Med Pediatr Oncol; 1996 Jun; 26(6):405-8. PubMed ID: 8614377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patency of 24-gauge peripheral intermittent infusion devices: a comparison of heparin and saline flush solutions.
    Mudge B; Forcier D; Slattery MJ
    Pediatr Nurs; 1998; 24(2):142-5, 149. PubMed ID: 9697567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of peripheral arterial catheter infection and comparison with concurrently sited central venous catheters.
    Koh DB; Gowardman JR; Rickard CM; Robertson IK; Brown A
    Crit Care Med; 2008 Feb; 36(2):397-402. PubMed ID: 18216598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparinized saline versus normal saline in maintaining patency of the radial artery catheter.
    Kulkarni M; Elsner C; Ouellet D; Zeldin R
    Can J Surg; 1994 Feb; 37(1):37-42. PubMed ID: 8306218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of heparinized and nonheparinized solutions for maintaining patency of arterial and pulmonary artery catheters.
    Zevola DR; Dioso J; Moggio R
    Am J Crit Care; 1997 Jan; 6(1):52-5. PubMed ID: 9116787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the effects of heparinized and nonheparinized flush solutions on the patency of arterial pressure monitoring lines: the AACN Thunder Project. By the American Association of Critical-Care Nurses.
    Am J Crit Care; 1993 Jan; 2(1):3-15. PubMed ID: 8353575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patency of arterial catheters with heparinized solutions versus non-heparinized solutions: a review of the literature.
    Lapum JL
    Can J Cardiovasc Nurs; 2006; 16(2):64-70. PubMed ID: 17153134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of 0.9% sodium chloride injection with or without heparin sodium for maintaining patency of intravenous catheters in children.
    Lombardi TP; Gundersen B; Zammett LO; Walters JK; Morris BA
    Clin Pharm; 1988 Nov; 7(11):832-6. PubMed ID: 3197384
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of normal saline and heparin solutions for maintenance of arterial catheter patency.
    Clifton GD; Branson P; Kelly HJ; Dotson LR; Record KE; Phillips BA; Thompson JR
    Heart Lung; 1991 Mar; 20(2):115-8. PubMed ID: 2004920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of the POP technique for restoring patency to occluded PIC catheters.
    Fetzer SJ; Manning GP
    Appl Nurs Res; 2004 Nov; 17(4):297-300. PubMed ID: 15573339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.